Analysis | Metabolite Name | Measured Value | Units | Organ | Cancer status | Smoker | Gender |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | trans-4-hydroxyproline | 36 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 37 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 41 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 52 | Peak area | Serum | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 60 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 63 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 65 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 71 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 79 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 81 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 85 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 111 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 164 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 241 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 250 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 257 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 288 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 293 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 297 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 303 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 329 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 330 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 345 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 346 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 350 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 365 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 372 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 373 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 387 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 418 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 419 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 423 | Peak area | Plasma | Adenosquamous | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 430 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 435 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 440 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 445 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 449 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 450 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 453 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 455 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 464 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 465 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 466 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 467 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 474 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 493 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 495 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 498 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 499 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 508 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 510 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 511 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 517 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 528 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 528 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 535 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 540 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 545 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 549 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 550 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 550 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 552 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 557 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 565 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 584 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 584 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 587 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 590 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 592 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 593 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 596 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 602 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 611 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 623 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 627 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 630 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 631 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 637 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 643 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 646 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 647 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 653 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 654 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 656 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 659 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 663 | Peak area | Plasma | Adenosquamous | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 664 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 667 | Peak area | Serum | Adenosquamous | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 682 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 682 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 692 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 701 | Peak area | Serum | Adenosquamous | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 704 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 711 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 712 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 713 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 718 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 735 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 739 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 747 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 749 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 753 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 773 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 783 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 785 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 793 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 799 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 811 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 818 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 831 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 839 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 842 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 850 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 854 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 863 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 870 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 878 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 891 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 915 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 921 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 922 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 927 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 931 | Peak area | Plasma | Adenocarcnoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 967 | Peak area | Serum | Adenocarcnoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 972 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 974 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 978 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 994 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 994 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 997 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1000 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1015 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1016 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1016 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1017 | Peak area | Serum | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1028 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1046 | Peak area | Plasma | NA | NA | NA |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1050 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1082 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1084 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1093 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1093 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1098 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1131 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1153 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1159 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1183 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1187 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1191 | Peak area | Serum | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1212 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1221 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1225 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1236 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1237 | Peak area | Serum | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1258 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1271 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1285 | Peak area | Serum | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1297 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1335 | Peak area | Plasma | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1338 | Peak area | Plasma | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1338 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1352 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1368 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1380 | Peak area | Serum | Adenocarcinoma | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1389 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1391 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1455 | Peak area | Plasma | Healthy | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1475 | Peak area | Plasma | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1547 | Peak area | Plasma | Adenocarcinoma | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1585 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1644 | Peak area | Plasma | Healthy | Current | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1667 | Peak area | Serum | Healthy | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1684 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1758 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1806 | Peak area | Serum | Healthy | Former | M |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1837 | Peak area | Plasma | Adenocarcinoma | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1919 | Peak area | Plasma | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 1927 | Peak area | Serum | Adenocarcinoma | Former | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 2177 | Peak area | Serum | Adenosquamous | Current | F |
GC POSITIVE ION MODE | trans-4-hydroxyproline | 2955 | Peak area | Plasma | Adenosquamous | Current | F |